Hematology/Oncology

Top Story

Earlier planning needed to improve end of life outcomes

June 20, 2019
Meeting NewsVideo

VIDEO: Talazoparib improves PFS in patients with BRCA mutations

June 20, 2019
CHICAGO — At the ASCO Annual Meeting, Jose Pablo Leone, MD, medical oncologist at Dana-Farber Cancer Institute, spoke with HemOnc Today about the findings of the…
In the Journals

Chronic pain inhibits daily life for 1 in 6 cancer survivors

June 20, 2019
About one in three cancer survivors, representing nearly 5.4 million people in the United States, reported experiencing chronic pain, with one in six survivors enduring…
Meeting NewsPerspective

Exercise reduces cancer-related fatigue, boosts muscle strength among patients with breast cancer

June 20, 2019
CHICAGO — Patients with breast cancer experienced reductions in cancer-related fatigue and improved muscle strength through an exercise regimen combining aerobic…
In the Journals

Breast cancer diagnosis tied to higher cardiometabolic risk in postmenopausal women

June 20, 2019
A cohort of postmenopausal women who received a breast cancer diagnosis were four times more likely to develop diabetes and metabolic syndrome and twice as likely to…
More Headlines »
CME

Updates in Hematologic Malignancies: What You Might Have Missed in San Diego

This activity is supported by an educational grant from Pharmacyclics LLC.

Therapeutic options continue to expand for patients with hematologic malignancies. The clinical evaluation of novel…
More »
Video
Meeting News

VIDEO: RET inhibitor shows promise in advanced NSCLC

June 15, 2019
More »
Resource Centers
HemOnc Today New York

HemOnc Today New York

CME ABIM MOC

Ace the Case: A 71-Year-Old Man With Muscle-Invasive Transitional Cell Bladder Cancer 6 Years Previously Presents With Back and Pelvic Pain That Began 2 Months Ago

There is no commercial support for this activity.

This educational activity will utilize a case study to discuss the management of a 71-year-old man with muscle-invasive…
More »
Current Issues
View the Current Issue
HemOnc Today Cell Therapy Next